The company is stepping up the production of Sputnik V, because it is aware of its great export potential and believes that it will very likely be approved by the World Health Organization and the European Medicines Agency
Biocad capable of producing 20 mln doses of Sputnik V a month — CEO
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться